branch cells from a patient's avow...

branch cells from a patient's avow bone marrow may be beneficial in treating coronary artery disease, according to a May 21 2003 recents release from the American association of Cardiology Foundation. Researchers in the United States and Israel took bone marrow lonely dwellings from the hips of 10 patients who were not responding to medication and could not be treated with angioplasty or bypass processs The cells were tittered, inspected, and checked for line clots. Patients then underwent a coronary angiogram and electromechanical mapping of the heart in a cardiac catheterization laboratory. Surgeon used a catheter with a needle threaded end major blood vessels to give each patient 12 injections of approximately 02 mL of his or her avow bone marrow in areas of the heart muscles affected by means of impaired blood flow. The scion cells should stimulate the expansion of new blood vessels.

chiefly of the patients experienced reduc chest pain and better coronary lie outspread flow after the procedure, and none undergoed adverse effects. After three month the patients demonstrated significantly improved Canadian Cardiovascular Society angina scores and stress-induced ischemia standard results.

This measure offers the potential to treat coronary artery disease at a stage that previously was conceit to be beyond therapy; however, more cogitation of the technique's effectiveness is necessary. Potential risks of the management include inflammatory reactions to the marrow injections or branch cells maturing into unwanted lonely dwelling types.

Bone Marrow main stock Cell Transplants May Offer of recent origin Way to Treat Blocked Arteries (new release, Bethesda, Md: American &liege of Cardiology Foundation, May 21 2003) http://www.acc.org/media/releases/highlights /2003/may03/marrow. htm (accessed 23 Nay 2003)

COPYRIGHT 2003 Association of Operating chamber Nurses, Inc.

COPYRIGHT 2003 Gale Group